Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (7)
- Torres AM, Marín EP, Díez PS, et al. Psychotic symptoms following ayahuasca use in a ceremonial setting. Prim Care Companion CNS Disord 2024;26(2):23cr03675
- Gonçalves J, Luís Â, Gallardo E, et al. A systematic review on the therapeutic effects of ayahuasca. Plants (Basel). 2023;12(13):2573.
- Hamill J, Hallak J, Dursun SM, et al. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Curr Neuropharmacol. 2019;17(2):108–128.
- Barabasz-Gembczyk A, Kucia K. Ayahuasca - potential therapeutic properties in psychiatry. Research review. Psychiatr Pol. 2020;54(2):381–389. PubMed CrossRef
- Dos Santos RG, Bouso JC, Hallak JEC. Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol. 2017;7(4):141–157. PubMed CrossRef
- Nižnanský Ľ, Nižnanská Ž, Kuruc R, et al. Ayahuasca as a decoction applied to human: analytical methods, pharmacology and potential toxic effects. J Clin Med. 2022;11(4):1147.
- James E, Keppler J, L Robertshaw T, et al. N,N dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol. 2022;37(3):e2835.
Please sign in or purchase this PDF for $40.